Lecture 6: Receptors and Signal Transduction Mechanisms Flashcards

1
Q

Endocrine signaling

A

Long distance communication. A hormone carried to the blood to a distinct target cell where it has effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Paracrine signalling

A

A secretory cell releases signalling molecules to an adjacent target cell, activating receptors on this cell. Could be across a synapse. Must have a neighbour for this type of signalling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Autocrine signalling

A

A cell releases a signalling ligand that feeds back to the cell that released it and binds to receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Signalling by plasma membrane attached proteins

A

The ligand is attached to one cell and binds to a receptor on an adjacent cell. The cells are conjoined by this arrangement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

For a drug to have selective action on a cell it muster interact with:

A

A discrete target (receptor) on that cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Receptors (what they are made of, where they are located)

A

Made of protein

Typically at the cell surface but also nuclear membrane proteins and even enzymes can act as receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Binding of drugs to receptors results in (3):

A
  • Conformational changes in receptor.
  • Transduction of the signal via alterations in cytosolic metabolism
  • Changes in cell function and gene transcription
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Orthosteric site

A

Where endogenous ligands bind a receptor. Most drugs mimic endogenous ligands, so they will also bind here. The receptor site that binds the neurotransmitter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Allosteric site

A

A distinct site on a receptor that the endogenous ligand doesn’t bind to. Can cause a change in the orthosteric site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ligand

A

Any endogenous neurotransmitter. Something that is recognized by and binds to a receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The 5 ways in which drugs can intervene in neuronal receptor signalling (neuronal modulation)

A
  1. Synthesis of transmitter in presynaptic nerve terminal
  2. Release of transmitter and transport to the target cell
  3. Detection of the signal by a specific receptor protein
  4. Change in cellular metabolism triggered by the receptor signalling molecule complex
  5. Removal of the signal, terminating the cellular response.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Receptor types

A
  • Ligand gated ion channel (LGIC)
  • GPCR
  • Receptor tyrosine kinases (RTK)
  • Nuclear receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Another term for LGIC

A

Ionotropic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LGICs

A
  • Present on cell membrane
  • Composed of 3-5 subunits and a central aqueous channel
  • Central pore requires binding of a ligand to change the conformation of the channel so that ions can pass through.
  • Involved in fast neurotransmission.
  • If the charge across the membrane is a favourable gradient, the ions will flow. NOT Voltage gated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Things that pass through LGICs

A

Na+, Ca2+, Cl-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Examples of LGICs

A
  • Nicotinic ACh (non-selective for sodium and calcium)
  • GABAᴬ: Inhibitory
  • 5-HT₃:
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How do LGIC and voltage gated ion channels differ?

A

While LGIC need favourable membrane potential for ions to flow through, they are gated by the binding of a ligand. VGICs don’t need this.

18
Q

Nicotinic Receptor Signalling

A
  • ACh is released and binds to its receptor
  • Receptor is able to pass sodium ions into the cell with the gradient
  • Small depolarizations in the muscle sum and cause action potentials and the muscle contracts.
19
Q

Acetylcholine Esterase

A
  • Membrane bound enzyme

- Hydrolyzes released ACh, producing choline and acetate that are recycled.

20
Q

Where are LGICs that respond to ACh normally found?

A

-Nerve synapses at neuromuscular junctions.

21
Q

Most drugs are targeted toward

A

GPCRs (at least 50%)

22
Q

GPCR Superfamily

A
  • Family A: Rhodopsin-like
  • Family B: Glucagon/ VIP/Calcitonin
  • Family C: Metabotropic glutamate and chemosensor
23
Q

GPCR features

A
  • 7 transmembrane domains
  • N terminal that is frequently extracellular
  • Intracellular carboxy terminal
24
Q

Function of IL3 loop

A

Slightly longer than others; has a function in binding downstream signalling molecules i.e. G-proteins

25
Q

C-terminus

A

Important in decreasing association of the receptor with the G-protein

26
Q

The G protein is inactive when bound to

A

GDP

27
Q

When an agonist that stabilizes the signalling form of the receptor binds, it allows:

A

Association with the G protein and the removal of GDP, so that it can bind GTP. The heterotrimeric g protein breaks apart, and the G-alpha subunit will signal downstream proteins.

28
Q

Effectors commonly associated with GPCRs (5)

A
  • Adenylyl cyclase
  • Phospholipases C & A2
  • cGMP Phosphodiesterase
  • Potassium channels
  • Calcium channels
29
Q

Orphan receptors and ligands

A

Things we see in research but haven’t been able to put them into a class because we dont know how they function.

30
Q

Steps of GPCR activation

A
  • Ligand binds orthosteric binding site. GDP is exchanged for GTP and the G protein associates with the receptor.
  • Dissociation of the heterotrimeric G protein. alpha-GTP goes to effector and activates it
  • Activation of effector is stopped when the alpha subunit hydrolyzes GTP. The heterotrimeric subunits come back together.
31
Q

Gs G-protein effector, intracellular signal, and signal change

A

Effector: adenylate cyclase
Intra Signal: Increase in cAMP
Signal change: Increase

32
Q

Gi G-protein effector, intracellular signal, and signal change

A

Effector: adenylate cyclase
Intra Signal: Decrease in cAMP
Signal Change: Can increase or decrease signalling, depending on the cell

33
Q

Gq G-protein effector, intracellular signal, and signal change

A

Effector: Phospholipid C
Intra Signal: DG, IP3, and Ca2+
Signal change: Increase in signalling. Involved in contraction

34
Q

cAMP and adenylyl cyclase signalling steps

A
  • Agonist binds receptor
  • alpha-GTP binds adenylyl cyclase
  • Production of cAMP (uses ATP)
  • Production of PKA enzyme
  • Protein phosphorylation by PKA.
35
Q

If a cell expresses both beta and alpha adrenergic receptors, what happens in the presence of adrenaline?

A
  • When bound to the beta receptor, adrenaline increases cAMP production
  • When bound to the alpha-2 receptor, there is coupling to Gi which inhibits adenylyl cyclase and decreases cAMP.

NET RESULT: Depends on which receptor is activated first, how long it is activated for, and how many of the receptors are present in the cell.

36
Q

Muscarinic receptor

A

GPCRs that respond with an IP3 signalling pathway

37
Q

Activation steps after acetylcholine binds to a Gq receptor

A
  • Activation of PLC enzyme
  • Hydrolyzing of membrane phospholipids, to make IP3 and DAG.
  • IP3 binds receptors on endoplasmic reticulum, dumping calcium into the cell.
  • DAG activates PKC, involved in protein phosphorylation
38
Q

Desensitization

A

Typically when you persistently expose a receptor to an agonist, you will not see signalling. Can involve down regulation of the receptor and can lead to drug tolerance.

39
Q

GPCR Desensitization

A

When agonist is present and binds the G protein, you get various enzymes (GRKs/PKA). These kinases target tails with serine residues. They add phosphates to the tails. Beta arrestin then moves in and associates with the GPCR, enabling GPCR internalization in clatherin pits. The GPCRs are in endosomes where the agonist is cleaved off, beta-arrestin dissociates and there is degradation (with long term exposure) or recycling.

40
Q

What is the main step that initiates GPCR desensitization?

A

Phosphorylation of the carboxy tail by GRKs and PKAs

41
Q

Cholera

A
  • Bacteria produces toxin
  • Toxin changes Gs protein activation, locking it in the on position (by transferring a sugar onto the G protein)
  • cAMP is needed for chloride conductance out of the cell by CFTR. When ions move, water must follow so there is a huge efflux of water into the gut, leading to watery diarrhea.